← Evidence map

ArticleAdvances in therapy2023

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom.

Hera Sandhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36630047